C21orf140
gene geneOn this page
Summary
C21orf140 (chromosome 21 open reading frame 140, HGNC:39602) is a protein-coding gene on chromosome 21q22.12, encoding Uncharacterized protein C21orf140 (B9A014).
At a glance
- MANE Select transcript:
NM_001282537
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:39602 |
| Approved symbol | C21orf140 |
| Name | chromosome 21 open reading frame 140 |
| Location | 21q22.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000222018 |
| Ensembl biotype | protein_coding |
| Entrez | 101928147 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000410005
RefSeq mRNA: 1 — MANE Select: NM_001282537
NM_001282537
CCDS: CCDS63357
Canonical transcript exons
ENST00000410005 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001579649 | 34400112 | 34401072 |
Expression profiles
Bgee: expression breadth ubiquitous, 130 present calls, max score 88.88.
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.88 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 71.04 | gold quality |
| stromal cell of endometrium | CL:0002255 | 70.19 | gold quality |
| prefrontal cortex | UBERON:0000451 | 68.51 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 68.46 | gold quality |
| primary visual cortex | UBERON:0002436 | 68.02 | gold quality |
| right testis | UBERON:0004534 | 67.29 | gold quality |
| right coronary artery | UBERON:0001625 | 66.67 | gold quality |
| left testis | UBERON:0004533 | 66.63 | gold quality |
| testis | UBERON:0000473 | 65.97 | gold quality |
| calcaneal tendon | UBERON:0003701 | 65.75 | gold quality |
| frontal cortex | UBERON:0001870 | 64.39 | gold quality |
| mucosa of stomach | UBERON:0001199 | 63.59 | gold quality |
| cortical plate | UBERON:0005343 | 63.56 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 63.50 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 62.79 | gold quality |
| body of uterus | UBERON:0009853 | 62.52 | gold quality |
| popliteal artery | UBERON:0002250 | 62.04 | gold quality |
| tibial nerve | UBERON:0001323 | 61.98 | gold quality |
| tibial artery | UBERON:0007610 | 61.97 | gold quality |
| fundus of stomach | UBERON:0001160 | 61.93 | gold quality |
| left ovary | UBERON:0002119 | 61.87 | gold quality |
| corpus callosum | UBERON:0002336 | 61.86 | gold quality |
| myometrium | UBERON:0001296 | 61.38 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 61.34 | gold quality |
| endocervix | UBERON:0000458 | 61.32 | gold quality |
| body of stomach | UBERON:0001161 | 61.28 | gold quality |
| colonic epithelium | UBERON:0000397 | 61.06 | silver quality |
| ovary | UBERON:0000992 | 60.98 | gold quality |
| lower esophagus | UBERON:0013473 | 60.82 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.17 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
8 targeting C21orf140, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-4316 | 99.37 | 65.75 | 1360 |
| HSA-MIR-628-3P | 99.04 | 68.37 | 814 |
| HSA-MIR-9898 | 99.00 | 67.89 | 500 |
| HSA-MIR-1294 | 98.91 | 69.26 | 1030 |
| HSA-MIR-9986 | 98.91 | 69.28 | 1024 |
| HSA-MIR-647 | 97.73 | 67.79 | 927 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Fam243 | ENSMUSG00000051728 |
| rattus_norvegicus | C11h21orf140 | ENSRNOG00000001986 |
Protein
Protein identifiers
Uncharacterized protein C21orf140 — B9A014 (reviewed: B9A014)
Alternative names: Protein FAM243A
All UniProt accessions (1): B9A014
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the FAM243 family.
RefSeq proteins (2): NP_001269466, NP_001351640 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR037728 | C21orf140-like | Family |
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-B9A014-F1 | 80.79 | 0.55 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 1 (showing top):
chr21q22
GO Biological Process (1): biological_process (GO:0008150)
GO Molecular Function (1): molecular_function (GO:0003674)
GO Cellular Component (1): cellular_component (GO:0005575)
Protein interactions and networks
STRING
62 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C21orf140 | C1orf53 | Q5VUE5 | 591 |
| C21orf140 | TEX29 | Q8N6K0 | 570 |
| C21orf140 | HIGD1C | A8MV81 | 518 |
| C21orf140 | HIGD1A | Q9Y241 | 370 |
| C21orf140 | DNAH3 | Q8TD57 | 369 |
| C21orf140 | GINS2 | Q9Y248 | 305 |
| C21orf140 | PKMYT1 | Q99640 | 305 |
| C21orf140 | OIP5 | O43482 | 299 |
| C21orf140 | MT1A | P04731 | 293 |
| C21orf140 | CDCA3 | Q99618 | 292 |
| C21orf140 | PCDH9 | Q9HC56 | 290 |
| C21orf140 | PMPCB | O75439 | 195 |
| C21orf140 | MUC16 | Q8WXI7 | 187 |
| C21orf140 | OPRM1 | P35372 | 178 |
| C21orf140 | CCER1 | Q8TC90 | 176 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| P | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A7H0DNF0, A1A5R7, B7F7B9, B9A014, F1MIW6, F4HZD1, F4JLK2, O14138, O14423, O23702, O60106, P0DSU9, P0DSV0, P24915, P34751, P36052, P38960, P49777, P52924, P70190, P86452, Q196W7, Q1L6Q1, Q4R7M8, Q5Q0E6, Q6IND4, Q6TEQ0, Q80HX3, Q80TC5, Q84RQ9, Q8CDS7, Q8CFL8, Q8L7T6, Q8QMP8, Q8V4S4, Q96KX2, Q9BR11, Q9DCE9, Q9FFN9, Q9FFP1
Diamond homologs: B9A014, F1MIW6, Q8CDS7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
308 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:34401003:T:TA | donor_gain | 0.9000 |
| 21:34400953:T:TA | donor_gain | 0.8700 |
| 21:34400951:A:C | donor_gain | 0.8000 |
| 21:34400975:A:AC | donor_gain | 0.7900 |
| 21:34400950:A:AC | donor_gain | 0.7700 |
| 21:34400950:AAAT:A | donor_gain | 0.7700 |
| 21:34400950:AAATC:A | donor_gain | 0.7600 |
| 21:34400976:G:C | donor_gain | 0.7600 |
| 21:34400826:AT:A | donor_gain | 0.7100 |
| 21:34400906:A:AC | donor_gain | 0.7100 |
| 21:34400907:C:CC | donor_gain | 0.7100 |
| 21:34400666:T:TA | donor_gain | 0.7000 |
| 21:34400942:A:AC | donor_gain | 0.6900 |
| 21:34400943:C:CC | donor_gain | 0.6900 |
| 21:34400907:CGAGA:C | donor_gain | 0.6800 |
| 21:34400943:CGGT:C | donor_gain | 0.6700 |
| 21:34400884:A:AC | donor_gain | 0.6600 |
| 21:34400903:G:C | donor_gain | 0.6600 |
| 21:34400961:A:AC | donor_gain | 0.6600 |
| 21:34401004:C:A | donor_gain | 0.6600 |
| 21:34400827:T:TA | donor_gain | 0.6500 |
| 21:34400653:AG:A | donor_gain | 0.6400 |
| 21:34400894:T:C | donor_gain | 0.6300 |
| 21:34400944:G:C | donor_gain | 0.6300 |
| 21:34400464:C:CC | acceptor_gain | 0.6200 |
| 21:34400930:T:A | donor_gain | 0.6200 |
| 21:34400931:C:A | donor_gain | 0.6200 |
| 21:34400939:T:C | donor_gain | 0.6200 |
| 21:34401028:T:TA | donor_gain | 0.6200 |
| 21:34400915:T:A | donor_gain | 0.6100 |
AlphaMissense
1664 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:34400826:A:G | W83R | 0.979 |
| 21:34400826:A:T | W83R | 0.979 |
| 21:34400379:A:G | W232R | 0.977 |
| 21:34400379:A:T | W232R | 0.977 |
| 21:34400497:A:C | F192L | 0.974 |
| 21:34400497:A:T | F192L | 0.974 |
| 21:34400499:A:G | F192L | 0.974 |
| 21:34400817:A:G | W86R | 0.973 |
| 21:34400817:A:T | W86R | 0.973 |
| 21:34400588:G:T | A162D | 0.971 |
| 21:34400406:C:G | G223R | 0.969 |
| 21:34400406:C:T | G223R | 0.969 |
| 21:34400843:G:T | A77D | 0.962 |
| 21:34400759:A:C | F105C | 0.959 |
| 21:34400859:A:G | W72R | 0.959 |
| 21:34400859:A:T | W72R | 0.959 |
| 21:34400750:A:G | F108S | 0.957 |
| 21:34400758:G:C | F105L | 0.957 |
| 21:34400758:G:T | F105L | 0.957 |
| 21:34400760:A:G | F105L | 0.957 |
| 21:34400473:A:C | F200L | 0.953 |
| 21:34400473:A:T | F200L | 0.953 |
| 21:34400475:A:G | F200L | 0.953 |
| 21:34400711:A:T | I121N | 0.953 |
| 21:34400517:A:G | W186R | 0.951 |
| 21:34400517:A:T | W186R | 0.951 |
| 21:34400988:A:C | Y29D | 0.951 |
| 21:34400345:T:A | E243V | 0.950 |
| 21:34400377:C:A | W232C | 0.948 |
| 21:34400377:C:G | W232C | 0.948 |
dbSNP variants (sampled 300 via entrez): RS1003184464 (21:34399854 G>A), RS1004251659 (21:34400832 G>A), RS1004579205 (21:34401878 C>T), RS1004672711 (21:34401916 C>G), RS1010492017 (21:34399876 G>A), RS1011603742 (21:34402808 G>A), RS1013498530 (21:34401183 A>G), RS1020859378 (21:34401558 A>T), RS1029664180 (21:34401900 G>A), RS1030101776 (21:34401867 C>T), RS1033985021 (21:34400847 G>A), RS1038711910 (21:34400957 T>A), RS1040319062 (21:34400752 C>T), RS1041455671 (21:34399785 CCT>C), RS1045013379 (21:34400354 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
1 total (human), top 1 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| clothianidin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.